Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinoma

dc.authoridOğul, Hayri/0000-0001-5989-3729
dc.contributor.authorOğul, Hayri
dc.contributor.authorKızıloğlu, Alper
dc.contributor.authorOğul, Yasemin
dc.date.accessioned2023-07-26T11:57:26Z
dc.date.available2023-07-26T11:57:26Z
dc.date.issued2023
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyoloji Ana Bilim Dalıen_US
dc.description.abstractSignificance Statement Posterior reversible encephalopathy syndrome (PRES) is characterized by variable neurological findings such as headache, deterioration in mental condition, loss of consciousness and visual loss. The disease results with impairment of the cerebral blood flow autoregulation. Ondansetron, serotonin (5HT-3) receptor antagonist, may cause the haemorrhagic PRES.en_US
dc.identifier.doi10.1177/01455613221150121
dc.identifier.issn0145-5613
dc.identifier.issn1942-7522
dc.identifier.pmid36592131en_US
dc.identifier.scopus2-s2.0-85145678471en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.1177/01455613221150121
dc.identifier.urihttps://hdl.handle.net/20.500.12684/13180
dc.identifier.wosWOS:000906850300001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorOğul, Hayri
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofEnt-Ear Nose & Throat Journalen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectHaemorrhagic Posterior Reversible Encephalopathy Syndrome; Ondensatron; Magnetic Resonance Imaging; Susceptibility Weighted Imagingen_US
dc.subjectSpectrumen_US
dc.titleHemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinomaen_US
dc.typeEditorialen_US

Dosyalar